Fig. 4From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimesCorrelation between uNAG and heart T2* MRI values. Positive correlation in All patients group (r = 0.47, p < 0.01). Positive correlation in patients treated with DFX (r = 0.54. p = 0.01). No correlation was found in patients treated with DFO+/−DFP (r = 0.2517; p = 0.4). Note that lower values for heart T2*MRI indicate worse cardiac function and increased cardiac iron content. (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) DeferiproneBack to article page